Jane Buus Laursen

Jane Buus Laursen holds significant leadership experience in the pharmaceutical and biotechnology sectors, currently serving as Corporate Vice President at Novo Nordisk and formerly as Vice President of Business Development & Alliance Management. Laursen has also contributed as a Board Observer at Amalgam Rx and a Member of the Board of Directors at Stayble Therapeutics. Prior experience includes various senior roles at AstraZeneca, such as Senior Director of Business Development in Pharmaceutical Technology and Development. Laursen holds a Ph.D. in Organic Chemistry and an M.Sc. in Chemistry from the Technical University of Denmark (DTU).